GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Asset Turnover

Quest PharmaTech (TSXV:QPT) Asset Turnover : 0.00 (As of Jul. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Quest PharmaTech's Revenue for the three months ended in Jul. 2024 was C$0.00 Mil. Quest PharmaTech's Total Assets for the quarter that ended in Jul. 2024 was C$23.76 Mil. Therefore, Quest PharmaTech's Asset Turnover for the quarter that ended in Jul. 2024 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Quest PharmaTech's annualized ROE % for the quarter that ended in Jul. 2024 was 12.72%. It is also linked to ROA % through Du Pont Formula. Quest PharmaTech's annualized ROA % for the quarter that ended in Jul. 2024 was 12.12%.


Quest PharmaTech Asset Turnover Historical Data

The historical data trend for Quest PharmaTech's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Asset Turnover Chart

Quest PharmaTech Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Quest PharmaTech Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Quest PharmaTech's Asset Turnover

For the Biotechnology subindustry, Quest PharmaTech's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest PharmaTech's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's Asset Turnover falls into.



Quest PharmaTech Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Quest PharmaTech's Asset Turnover for the fiscal year that ended in Jan. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jan. 2024 )/( (Total Assets (A: Jan. 2023 )+Total Assets (A: Jan. 2024 ))/ count )
=0/( (26.802+24.476)/ 2 )
=0/25.639
=0.00

Quest PharmaTech's Asset Turnover for the quarter that ended in Jul. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jul. 2024 )/( (Total Assets (Q: Apr. 2024 )+Total Assets (Q: Jul. 2024 ))/ count )
=0/( (23.435+24.079)/ 2 )
=0/23.757
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Quest PharmaTech  (TSXV:QPT) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Quest PharmaTech's annulized ROE % for the quarter that ended in Jul. 2024 is

ROE %**(Q: Jul. 2024 )
=Net Income/Total Stockholders Equity
=2.88/22.6445
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(2.88 / 0)*(0 / 23.757)*(23.757/ 22.6445)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*1.0491
=ROA %*Equity Multiplier
=12.12 %*1.0491
=12.72 %

Note: The Net Income data used here is four times the quarterly (Jul. 2024) net income data. The Revenue data used here is four times the quarterly (Jul. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Quest PharmaTech's annulized ROA % for the quarter that ended in Jul. 2024 is

ROA %(Q: Jul. 2024 )
=Net Income/Total Assets
=2.88/23.757
=(Net Income / Revenue)*(Revenue / Total Assets)
=(2.88 / 0)*(0 / 23.757)
=Net Margin %*Asset Turnover
= %*0
=12.12 %

Note: The Net Income data used here is four times the quarterly (Jul. 2024) net income data. The Revenue data used here is four times the quarterly (Jul. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Quest PharmaTech Asset Turnover Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest PharmaTech Business Description

Traded in Other Exchanges
N/A
Address
8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Executives
Ragupathy Madiyalakan Director
William John Meekison Director

Quest PharmaTech Headlines

No Headlines